NCT00078013View on ClinicalTrials.gov

MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

August 31, 2004

Conditions
Myocardial Infarction
Interventions
DRUG

MCC-135

Trial Locations (1)

02114

Massachusetts General Hospital/ Harvard Medical School, Boston

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY